News

The recognition of a previously unidentified genetic cause of late-onset cerebellar ataxia is reported in a new study that was released recently in the New England Journal of Medicine. This finding will help with the diagnosis and open up...

Antibiotic usage is crucial in the treatment of many bacterial infections. However, the quantity of bacteria strains that are impervious to numerous antibiotics is increasing as a result of ongoing overuse and misuse, which is hurting millions of people...

Data shown at the 64th American Society of Haematology (ASH) conference in New Orleans demonstrates that elranatamab is effective and has a controllable effectiveness and safety in patients with relapsed or refractory multiple myeloma (RRMM). Multiple myeloma (MM) is a...

The generic version of the COVID-19 oral antiviral therapy candidate nirmatrelvir has been approved by the World Health Organization Prequalification of Medicines Program (WHO PQ), as stated by the Indian pharmaceutical company Hetero. This is the first prequalification for a...

BioNTech SE announced the initiation of a first-in-human Phase 1 study with BNT165b1, the first candidate from the Company’s BNT165 program, to develop a multi-antigen malaria vaccine candidate. BioNTech will initially evaluate a set of mRNA-encoded antigens of the...

BioNTech SE and Shanghai Fosun Pharmaceutical announced that the companies provided approximately 11,500 doses of mRNA-based COVID-19 vaccines which arrived on the Chinese Mainland on December 21, 2022. The delivery contains both the companies’ Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine...

Researchers in Singapore have identified a brand-new therapeutic target called ADAM10 that may be used to treat people who have diabetic retinopathy (DR), a disorder that is brought on by untreated diabetes and results in blindness. A typical symptom of...